Gastric conduit resection and jejunal interposition for recurrent esophageal cancer

Ann Thorac Surg. 2012 May;93(5):1727-9. doi: 10.1016/j.athoracsur.2011.09.076.

Abstract

We describe the case of a 58-year-old man with recurrent adenocarcinoma at the site of an esophagogastrostomy that we treated by radical surgical resection and jejunal interposition. Oral intake was started on the 6th postoperative day and the patient was discharged on the 11th postoperative day. Seven months after the surgical procedure no signs of tumor recurrence were detected. Resection of localized (recurrent) esophageal cancer may well be a valuable treatment option and is therefore an interesting therapeutic option in patients with recurrent disease. However this needs to be investigated in a randomized controlled trial.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / therapy*
  • Anastomosis, Surgical
  • Chemoradiotherapy / methods
  • Combined Modality Therapy
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / therapy*
  • Esophagectomy / methods
  • Esophagogastric Junction / pathology
  • Esophagogastric Junction / surgery*
  • Follow-Up Studies
  • Gastrectomy / methods
  • Humans
  • Jejunum / surgery*
  • Laparotomy / methods
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / surgery*
  • Plastic Surgery Procedures / methods
  • Risk Assessment
  • Stomach / surgery*
  • Transplantation, Autologous
  • Treatment Outcome